Article Text
Extended Report
Safety Analyses of Adalimumab (HUMIRA®) in Global Clinical Trials and US Postmarketing Surveillance of Patients With Rheumatoid Arthritis
Statistics from Altmetric.com
This is a PDF-only article. The first page of the PDF of this article appears above.
Supplementary materials
Files in this Data Supplement: